ASTH Shorts Ease as Analysts Line Up Behind Astrana
Astrana Health heads into the final stretch of Q3 trading with an unusual tension: the stock is down 8.5% on the week yet the Street is firmly bullish, shorts are quietly retreating, and the lending market offers no…